欢迎访问行业研究报告数据库

行业分类

当前位置:首页 > 报告详细信息

找到报告 1 篇 当前为第 1 页 共 1

苯丙酮尿症的辅助治疗:执行概要-有效的医疗保健计划

Adjuvant Treatment for Phenylketonuria (PKU). Executive Summary. Effective Health Care Program
作者:Lindegreen, M. L.Krishnaswami, S.Fonnesbeck, C.Reimschisel, T.Fisher, J.Jackson, K.Shields, T.Sathe, N. A.McPheeters, M. L. 作者单位:Vanderbilt Univ., Nashville, TN. Div. of Sponsored Research.;Agency for Healthcare Research and Quality, Rockville, MD. 加工时间:2014-09-19 信息来源:科技报告(PB) 索取原文[16 页]
关键词:苯丙酮酸尿;代谢疾病;氨基酸;血液;诊断(医学)
摘 要:Phenylketonuria (PKU) is a metabolic disorder in which an inability to properly metabolize the amino acid phenylalanine (Phe) leads to a buildup of Phe in the blood, causing neurotoxicity and resulting in intellectual disability, delayed speech, seizures, and behavior abnormalities. Individuals with PKU are also susceptible to other adverse outcomes, including impaired executive function, reduced processing speed, attention problems, impaired fine motor skills, and mental health concerns (such as anxiety and depression symptoms). The most severe form of PKU, classic PKU, is typically characterized by blood Phe levels exceeding 1,200 umol/L while on a normal diet. PKU is typically diagnosed at birth following abnormal newborn screening results. With adherence to a Phe-restricted diet, poor outcomes can be mitigated.
© 2016 武汉世讯达文化传播有限责任公司 版权所有
客服中心

QQ咨询


点击这里给我发消息 客服员


电话咨询


027-87841330


微信公众号




展开客服